1.
Barnes, R.C. Laboratory diagnosis of human chlamydial
infections. Clin Microbiol Rev 1989 2(2):119-36.
2.
Holmes, K.K., Handsfield, H., Wang, S.P., Wentworth, B.B.,
Turck, M., Anderson, J.B., Alexander, E.R. Etiology
of nongonococcal urethritis. N Engl J Med 1975 Jun
5 292(23): 1199-205.
3.
Rolfs, R.T., Galaid, E.I., Zaidi, A.A. Pelvic inflammatory
disease: trends in hospitalizations and office visits,
1979 through 1988. Am J Obstet Gynecol 1992 Mar 166(3):983-90.
4.
Centers for Disease Control. Pelvic inflammatory disease:
guidelines for prevention and management. MMWR 1991
Apr 26 40(RR-5): 1-25.
5.
Washington, A.E., Katz, P. Cost of and payment source
for pelvic inflammatory disease: trends and projections,
1983 through 2000. JAMA 1991 Nov 13 266(18):2565-9.
6.
Washington, A.E., Johnson, R.E., Sanders Jr., L.L. Chlamydia
trachomatis infections in the Unitd States: what are they
costing us? JAMA 1987 Apr 17 257(15):2070-2.
7.
Centers for Disease Control and Prevention. Sexually
transmitted diseases treatment guidelines. MMWR 1993
Sep 24 42(RR-14):1-102.
8.
Litwin, J. The growth cycle of the psittacosis group of
micro-organisms. J Infect Dis 1959 105:129-60.
9.
Moulder, J.W. Characteristics of Chlamydiae. In:
Barron AL, editor. Microbiology of Chlamydia. Boca
Raton, FL:CRC Press; 1988. p 3-19.
10.
Matsumoto, A., Higashi, N. Electron microscopic observations
of DNA molecules of the mature, elementary bodies of Chlamydia
psittaci. Ann Rep Inst Virus Res, Kyoto Univ 1973;16:33-9.
11.
Schachter, J. Chlamydiae (psittacosis-lymphogranuloma
venereum-trachoma group). In: Lennette, E.H., Balows,
A., Hausler, W.J., Jr., Shadomy, H.J., editors. Manual
of Clinical Microbiology. 4th ed. Washington, DC:
American Society for Microbiology; 1985. p 856-62.
12.
Stephens, R.S., Tam, M.R., Kuo, C., Nowinski, R.C. Monoclonal
antibodies to Chlamydia trachoma tis: antibody specificities
and antigen characterization. J ImmunoI 1982 128(3):1083-9.
13.
Stamm, W.E., Tam, M., Koester, M., Cles, L. Detection
of Chlamydia trachomatis inclusions in McCoy cell cultures
with fluorescein-conjugated monoclonal antibodies.
J Clin MicrobioI 1983 17(4):666-8.
14.
Ripa, K.T., Mardh, P. Cultivation of Chlamydia trachoma
tis in cycloheximide-treated McCoy cells. J Clin Microbiol
1977 6(4):328-31.
15.
Chernesky, M.A., Mahony, J.B., Castriciano, S., Mores,
M., Stewart, I.O., Landis, S.J., Seidelman, W., Sargeant,
E.J., Leman, C. Detection of Chlamydia trachomatis
antigens by enzyme immunoassay and immunofluorescence
in genital specimens from symptomatic and asymptomatic
men and women. J Infect Dis 1986 154(1):141-8.
16.
Horn, J.E., Quinn, T., Hammer, M., Palmer, L., Falkow,
S. Use of nucleic acid probes for the detection of
sexually transmitted infectious agents. Diagn Microbiol
lnfect Dis 1986 4:101S-9S.
17.
Palmer, L., Falkow, S. A common plasmid of Chlamydia
trachomatis. Plasmid 1986;16:52-62.
18.
Bobo, L., Coutlee, F., Yolken, R.H., Quinn, T., Viscidi,
R.P. Diagnosis of Chlamydia trachomatis cervical infection
by detection of amplified DNA with an enzyme immunoassay.
J Clin MicrobioI1990 28(9):1968-73.
19.
Moulder, J.W. Characteristics of Chlamydiae. In:
Barron, A.L., editor. Microbiology of Chlamydia.
Boca Raton, FL: CRC Press; 1988. p 3-19.
20.
Sehulster, L.M., Hollinger, F.B., Dreesman, G.R., Melnick,
J.L. Immunological and biophysical alteration of hepatitis
B virus antigens by sodium hypochlorite disinfection.
Appl Environ Microbiol 1981 Nov 42(5):762-7.
21.
Spire, B., Barre-Sinoussi, F., Montagnier, L., Chermann,
J.C. Inactivation of lymphadenopathy associated virus
by chemical disinfectants. Lancet 1984 Oct 20 2(8408):899-901.
22.
Martin, L.S., McDougal, J.S., Loskoski, S.L. Disinfection
and inactivation of the human T Iymphotropic virus type
III1 lymphadenopathy-associated virus. J Infect Dis
1985 Aug 152(2):400-3.
--------------------------------------------------------------
